...
首页> 外文期刊>Molecular Genetics & Genomic Medicine >Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods
【24h】

Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods

机译:综合生物信息学方法鉴定和分析头颈鳞状细胞癌相关的基因

获取原文

摘要

Background Head and neck squamous cell carcinoma (HNSCC) is one of the most common cancers worldwide, exhibiting high morbidity and mortality. The prognosis of HNSCC patients has remained poor, though considerable efforts have been made to improve the treatment of this cancer. Therefore, identifying significant differentially expressed genes (DEGs) involved in HNSCC progression and exploiting them as novel biomarkers or potential therapeutic targets for HNSCC is highly valuable. Methods Overlapping differentially expressed genes (DEGs) were screened out from three independent gene expression omnibus (GEO) datasets and subjected to GO and kyoto encyclopedia of genes and genomes pathway enrichment analyses. The protein–protein interactions network of DEGs was constructed in the STRING database, and the top ten hub genes were selected using cytoHubba. The relative expression of hub genes was detected in GEPIA, Oncomine, and human protein atlas (HPA) databases. Furthermore, the relationship of hub genes with the overall survival and disease‐free survival in HNSCC patients was investigated using the cancer genome atlas data. Results The top ten hub genes (SPP1, POSTN, COL1A2, FN1, IGFBP3, APP, MMP3, MMP13, CXCL8, and CXCL12) could be utilized as potential diagnostic indicators for HNSCC. The relative levels of FN1, APP, SPP1, and POSTN could be associated with the prognosis of HNSCC patients. The mRNA expression of APP and COL1A2 was validated in HNSCC samples. Conclusion This study identified effective and reliable molecular biomarkers for diagnosis and prognosis by integrated bioinformatics analysis, suggesting novel and essential therapeutic targets for HNSCC.
机译:背景头和颈部鳞状细胞癌(HNSCC)是全球最常见的癌症之一,表现出高发病率和死亡率。 HNSCC患者的预后仍然贫困,尽管已经进行了大量努力,以改善这种癌症的治疗。因此,鉴定参与HNSCC进展中的显着差异表达的基因(DEG)并利用作为新型生物标志物或HNSCC的潜在治疗靶标非常有价值。方法从三个独立的基因表达综合征(Geo)数据集中筛选重叠差异表达的基因(DEGS),并进行GO和京都基因群和基因组途径富集分析。 DEG的蛋白质 - 蛋白质相互作用网络在串数据库中构建,使用CytoHubba选择前十个轮毂基因。肠道基因的相对表达在肠道,oncomsine和人蛋白地图集(HPA)数据库中检测到。此外,使用癌症基因组地图集数据研究了HUB基因与HNSCC患者的整体存活和无病生存的关系。结果前十个轮毂基因(SPP1,Postn,Col1a2,Fn1,IGFBP3,APP,MMP3,MMP13,CXCL8和CXCL12)可用作HNSCC的潜在诊断指标。 FN1,APP,SPP1和Postn的相对水平可能与HNSCC患者的预后相关。 APP和COL1A2的mRNA表达在HNSCC样品中验证。结论本研究确定了通过综合生物信息化分析诊断和预后的有效且可靠的分子生物标志物,表明HNSCC的新颖和基本治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号